A. Feijen

2.1k total citations
31 papers, 1.8k citations indexed

About

A. Feijen is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, A. Feijen has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Cell Biology. Recurrent topics in A. Feijen's work include TGF-β signaling in diseases (15 papers), Pluripotent Stem Cells Research (7 papers) and Kruppel-like factors research (6 papers). A. Feijen is often cited by papers focused on TGF-β signaling in diseases (15 papers), Pluripotent Stem Cells Research (7 papers) and Kruppel-like factors research (6 papers). A. Feijen collaborates with scholars based in Netherlands, United States and Belgium. A. Feijen's co-authors include Christine L. Mummery, Marie‐José Goumans, Siegfried W. de Laat, Patricia K. Donahoe, C.E. van den Brink, A.J.M. van den Eijnden-van Raaij, Paul T. van der Saag, W. Kruijer, Koen J. Dechering and Wiebe Olijve and has published in prestigious journals such as Circulation, Genes & Development and Development.

In The Last Decade

A. Feijen

31 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Feijen Netherlands 22 1.6k 327 212 187 106 31 1.8k
Ezra Wiater United States 20 1.5k 1.0× 247 0.8× 154 0.7× 218 1.2× 163 1.5× 24 1.9k
J M Alexander United States 21 1.7k 1.1× 338 1.0× 343 1.6× 194 1.0× 48 0.5× 27 2.7k
Marko Uutela Finland 11 998 0.6× 227 0.7× 206 1.0× 390 2.1× 87 0.8× 13 1.8k
Lori C. Gowen United States 12 1.2k 0.8× 492 1.5× 159 0.8× 440 2.4× 102 1.0× 13 1.8k
Marja Nissinen Finland 14 1.2k 0.7× 358 1.1× 151 0.7× 54 0.3× 128 1.2× 19 2.2k
Andrew Beenken United States 9 1.6k 1.0× 238 0.7× 233 1.1× 164 0.9× 59 0.6× 11 2.0k
Lilia Topol United States 12 1.9k 1.2× 457 1.4× 211 1.0× 230 1.2× 304 2.9× 21 2.5k
Samir Zaidi United States 12 1.2k 0.8× 326 1.0× 195 0.9× 257 1.4× 39 0.4× 20 1.8k
Cecilia Bondjers Sweden 11 838 0.5× 181 0.6× 111 0.5× 131 0.7× 32 0.3× 11 1.3k
Astrid Hoebertz Austria 12 737 0.5× 132 0.4× 91 0.4× 373 2.0× 136 1.3× 17 1.4k

Countries citing papers authored by A. Feijen

Since Specialization
Citations

This map shows the geographic impact of A. Feijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Feijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Feijen more than expected).

Fields of papers citing papers by A. Feijen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Feijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Feijen. The network helps show where A. Feijen may publish in the future.

Co-authorship network of co-authors of A. Feijen

This figure shows the co-authorship network connecting the top 25 collaborators of A. Feijen. A scholar is included among the top collaborators of A. Feijen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Feijen. A. Feijen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassink, Rutger J., A. Feijen, Marga A. van Rooijen, et al.. (2006). Patterning the heart, a template for human cardiomyocyte development. Developmental Dynamics. 235(7). 1994–2002. 57 indexed citations
2.
Lopes, Susana M. Chuva de Sousa, A. Feijen, Jeroen Korving, et al.. (2004). Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Developmental Dynamics. 231(3). 542–550. 86 indexed citations
3.
Feijen, A., et al.. (2000). Expression patterns of follistatin and two follistatin-related proteins during mouse development. The International Journal of Developmental Biology. 44(3). 327–330. 12 indexed citations
4.
Winter, Johan P. de, Carlie J.M. de Vries, Tanja A.E. van Achterberg, et al.. (1996). Truncated Activin Type II Receptors Inhibit Activin Bioactivity by the Formation of Heteromeric Complexes with Activin Type I Receptors. Experimental Cell Research. 224(2). 323–334. 22 indexed citations
5.
Schoorlemmer, Jon, et al.. (1995). Regulation of Oct-4 gene expression during differentiation of EC cells. Molecular Biology Reports. 21(3). 129–140. 32 indexed citations
6.
Kruijssen, Cornelia M.M. van der, et al.. (1995). Neuronal and mesodermal differentiation of P19 embryonal carcinoma cells is characterized by expression of specific marker genes and modulated by activin and fibroblast growth factors. Development Growth & Differentiation. 37(5). 559–574. 4 indexed citations
7.
Verschueren, Kristin, Nathalie de Lourdes Souza Dewulf, Marie‐José Goumans, et al.. (1995). Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis. Mechanisms of Development. 52(1). 109–123. 94 indexed citations
9.
Slager, H.G., Eric Freund, A. M. J. Buiting, A. Feijen, & Christine L. Mummery. (1993). Secretion of transforming growth factor‐β isoforms by embryonic stem cells: Isoform and latency are dependent on direction of differentiation. Journal of Cellular Physiology. 156(2). 247–256. 25 indexed citations
10.
Kruijssen, Cornelia M.M. van der, A. Feijen, Danny Huylebroeck, & A.J.M. van den Eijnden-van Raaij. (1993). Modulation of Activin Expression by Type β Transforming Growth Factors. Experimental Cell Research. 207(2). 407–412. 14 indexed citations
11.
Mummery, Christine L., et al.. (1992). Survey of Neuropeptide Gene Expression in Tumor Cell Lines. Pathobiology. 60(3). 127–135. 9 indexed citations
12.
Kruyt, Frank A.E., C.E. van den Brink, A. Feijen, et al.. (1992). Retinoic acid resistance of the variant embryonal carcinoma cell line RAC65 is caused by expression of a truncated RARα. Differentiation. 49(1). 27–37. 40 indexed citations
13.
Raaij, A.J.M. van den Eijnden-van, A. Feijen, Kirstie A. Lawson, & Christine L. Mummery. (1992). Differential expression of inhibin subunits and follistatin, but not of activin receptor type II, during early murine embryonic development. Developmental Biology. 154(2). 356–365. 36 indexed citations
14.
15.
Mummery, Christine L., H.G. Slager, W. Kruijer, et al.. (1990). Expression of transforming growth factor β2 during the differentiation of murine embryonal carcinoma and embryonic stem cells. Developmental Biology. 137(1). 161–170. 63 indexed citations
16.
Mummery, Christine L., A.J.M. van den Eijnden-van Raaij, A. Feijen, et al.. (1990). Expression of growth factors during the differentiation of embryonic stem cells in monolayer. Developmental Biology. 142(2). 406–413. 39 indexed citations
18.
Weima, Sjerp M., Marga A. van Rooijen, A. Feijen, et al.. (1989). Transforming growth factor-β and its receptor are differentially regulated in human embryonal carcinoma cells. Differentiation. 41(3). 245–253. 12 indexed citations
19.
Weima, Sjerp M., Marga A. van Rooijen, Christine L. Mummery, et al.. (1988). Differentially regulated production of platelet-derived growth factor and of transforming growth factor beta by a human teratocarcinoma cell line. Differentiation. 38(3). 203–210. 17 indexed citations
20.
Raaij, A.J.M. van den Eijnden-van, A. Feijen, & Gerry T. Snoek. (1987). EDTA-extractable proteins from calf lens fiber membranes are phosphorylated by Ca2+-phospholipid-dependent protein kinase. Experimental Eye Research. 45(2). 215–225. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026